Exicure Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.25

-0.06 (-4.58%)

As of Aug 14, 10:14 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +2,365.6% upside

Low Target $21.30

Average Target $30.82

High Target $34.43

Current Price $1.25

Current
$1.25

Target
$30.82

$21.30 $30.82 avg $34.43

Scenario Analysis

Bear Case

$21.30

1,604.0%

Low target

Base Case

$30.82

+2,365.6%

Avg target

Bull Case

$34.43

+2,654.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$9.48

-86.8% from high

52-Week Low

$1.30

+-3.8% from low

Target vs 52W High

$30.82

+225.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%